Catalent

Investor Center

Catalent Pharma Solutions is the leading provider of advanced technologies, and development, manufacturing and packaging services and solutions for pharmaceutical, biotechnology and consumer healthcare companies in nearly 100 countries. The company applies its local market expertise and technical creativity to advance treatments, change markets and enhance patient outcomes. Catalent employs approximately 9,100 at 30 facilities worldwide.

Investor News

 Quarterly Report on Form 10-Q for 2Q FY 10 - Filed February 12, 2010

Thursday, February 12th, 2010 10:00 am EST
Second Quarter 2010 Earnings Call
Windows Media Player required
Click here for Webcast Replay

Second Quarter Fiscal 2010 Investor Call Slides - February 12, 2010

Current Report on Form 8-K on February 12, 2010 - 2Q10 Earnings Announcement

Quarterly Report on Form 10-Q for 1Q FY 10 - November 13, 2009

First Quarter Fiscal 2010 Investor Call Slides - November 12, 2009

Current Report on Form 8-K on November 12, 2009 - 1Q10 Earnings Announcement

First Quarter Fiscal 2010 Earnings Announcement Details - November 10, 2009

Annual Repot on Form 10-K for Fiscal 2009 - September 28, 2009

Fourth Quarter Fiscal 2009 Investor Call Slides - September 25, 2009

Current Report on Form 8-K on September 25, 2009 - 4Q09 Earnings Announcement

Fourth Quarter Fiscal 2009 Earnings Announcement Details

Quarterly Report on Form 10-Q as of March 31, 2009

Current Report on Form 8-K on May 14, 2009 – 3Q09 Earnings Announcement

Third Quarter Fiscal 2009 Earnings Call Slides

Third Quarter Fiscal 2009 Earnings Announcement Details

 
 

Recent News

Investor Contact
Investor Relations Dept
Catalent Pharma Solutions
14 Schoolhouse Road
Somerset, NJ 08873
Phone 732 537 6325
Fax 732 537 5932
investors@catalent.com

Catalent Pharma Solutions
14 Schoolhouse Road
Somerset, NJ 08873
732 537 6200

Email: